CADTH's $50,000 Cost-Effectiveness Threshold: Fact or Fiction?

Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

Previous Article
Review of Clinical Practice Guidelines and Treatment Patterns in Metastatic Pancreatic Cancer in EU-5 Countries
Review of Clinical Practice Guidelines and Treatment Patterns in Metastatic Pancreatic Cancer in EU-5 Countries

Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

Next Article
Swedish Perspective On Health Technology Assesments With Incrementally Lower Costs and Effects
Swedish Perspective On Health Technology Assesments With Incrementally Lower Costs and Effects

Educational poster presented at ISPOR 20th Annual European Congress, November 2017